Medicare Enrolled
Dr. Waqar Khan, MD
Cardiovascular Disease · Tomball, TX
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Waqar Khan is a cardiovascular disease in Tomball, TX, with 20 years in practice. Based on federal Medicare data, Dr. Khan performed 5,513 Medicare services across 3,125 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $23,712 from 56 pharmaceutical and/or device companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 13% volume in TX$ $23,712 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,513
Medicare services
Top 13% in TX for cardiovascular disease
3,125
Unique beneficiaries
$152
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~276 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,169 | $95 | $405 |
| Electrocardiogram (EKG), 12-lead | 723 | $11 | $50 |
| Regadenoson injection (Lexiscan) for heart stress test | 652 | $44 | $170 |
| Hospital follow-up visit, moderate complexity | 345 | $65 | $220 |
| Echocardiogram, transthoracic | 263 | $142 | $1,300 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 263 | $33 | $120 |
| Remote patient monitoring management, 20 min/month | 184 | $40 | $150 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 172 | $57 | $210 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 147 | $1,977 | $6,890 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 147 | $626 | $798 |
| Ultrasound of both sides of head and neck blood flow | 146 | $145 | $630 |
| Ultrasound of leg arteries or artery grafts | 96 | $197 | $805 |
| Initial hospital admission, moderate complexity | 94 | $108 | $420 |
| Remote patient monitoring device, 30 days | 92 | $41 | $150 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 88 | $145 | $620 |
| Remote pacemaker/defibrillator monitoring, 90 days | 83 | $18 | $80 |
| Remote pacemaker monitoring, 90 days | 76 | $24 | $95 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 74 | $871 | $4,012 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 72 | $16 | $55 |
| Hospital follow-up visit, high complexity | 63 | $96 | $320 |
| New patient office visit (45-59 min) | 59 | $135 | $525 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 58 | $98 | $390 |
| EKG interpretation and report | 51 | $7 | $27 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 42 | $21 | $80 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 42 | $693 | $2,215 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 40 | $42 | $175 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | $10 | $40 |
| Programming of dual lead pacemaker system | 33 | $52 | $250 |
| Cardiac catheterization | 32 | $166 | $915 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $362 | $2,250 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 23 | $55 | $490 |
| Injection of chemical agent into multiple incompetent veins of leg | 21 | $135 | $635 |
| Ultrasonic guidance for needle placement | 20 | $45 | $182 |
| Coronary stent placement | 19 | $409 | $1,825 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $16 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $11 | $45 |
| Office visit, established patient, complex (40-54 min) | 13 | $137 | $565 |
| Insertion of permanent leadless pacemaker using imaging guidance | 12 | $400 | $1,500 |
| Review by radiologist of abdominal aorta image | 12 | $56 | $1,068 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.1% high complexity
27.3% medium
62.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,712
Total received (2018-2024)
Avg $3,387/year across 7 years
Top 17% in TX for cardiovascular disease
56
Companies
490
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,712 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,130
2023$5,107
2022$4,715
2021$2,174
2020$3,283
2019$3,606
2018$3,695
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$6,122
Medtronic, Inc.
$4,791
Boston Scientific Corporation
$4,110
Abbott Laboratories
$2,944
Janssen Pharmaceuticals, Inc
$794
Bard Peripheral Vascular, Inc.
$536
Amgen Inc.
$455
Novartis Pharmaceuticals Corporation
$415
Merck Sharp & Dohme LLC
$334
Esperion Therapeutics, Inc.
$296
AstraZeneca Pharmaceuticals LP
$250
Impulse Dynamics (USA) Inc.
$178
Merz North America, Inc.
$176
E.R. Squibb & Sons, L.L.C.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$155
SANOFI-AVENTIS U.S. LLC
$155
BOSTON SCIENTIFIC CORPORATION
$132
BARD PERIPHERAL VASCULAR, INC.
$128
HEARTFLOW, INC.
$121
ABIOMED
$105
CashFlow Solutions, LLC
$93
Actelion Pharmaceuticals US, Inc.
$92
Biosense Webster, Inc.
$90
PFIZER INC.
$89
Baxter Healthcare
$75
Lexicon Pharmaceuticals, Inc.
$63
Merck Sharp & Dohme Corporation
$56
Tactile Systems Technology Inc
$55
Ra Medical Systems, Inc.
$50
Astellas Pharma US Inc
$45
Chiesi USA, Inc.
$38
Edwards Lifesciences Corporation
$35
AngioDynamics, Inc.
$29
KCI USA, Inc.
$27
CHF Solutions, Inc
$26
CeloNova BioSciences, Inc.
$24
Kestra Medical Technology Services, Inc.
$24
Novo Nordisk Inc
$23
ARALEZ PHARMACEUTICALS US INC.
$23
BIOTRONIK INC.
$22
Cook Medical LLC
$21
Relypsa, Inc.
$21
Cardiovascular Systems Inc.
$19
Gilead Sciences, Inc.
$18
Amicus Therapeutics, Inc.
$16
SCPHARMACEUTICALS INC.
$16
Arbor Pharmaceuticals, Inc.
$15
Arrow International, Inc.
$14
BSN Medical Inc
$13
ARBOR PHARMACEUTICALS, INC.
$12
Alnylam Pharmaceuticals Inc.
$12
InfoBionic, Inc
$11
Allergan Inc.
$11
Venclose Inc.
$10
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 63.4% of total payments
Associated products mentioned in payments ›
ACCOLADE · ACTIMOVE · ACTIV.A.C. · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AZURE XT DR MRI SURESCAN · Amplia MRI · Aquadex · Assure WCD · Assurity Pacemaker · BRILINTA · BYSTOLIC · CAMZYOS · CARDENE · CARDIOMEMS · CARTO 3 · COBALT DR MRI SURESCAN · CONFIRM RX · Carnation Ambulatory Monitor · Claria MRI · Confirm Rx · Connectivity and Remote care · Corlanor · DABRA · ELIQUIS · EMBLEM · ENDURANT IIS · ENTRESTO · Edarbi · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · Euphora · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · Flexitouch Plus · GENERAL THERAPIES · GENERAL - VASCULAR INTERVENTION · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hillrom - Carnation Ambulatory Monitor · INVOKANA · Impella · Inpefa · JARDIANCE · KENGREAL · LATITUDE · LEQVIO · LEXISCAN · LIFESTENT · LIFESTREAM · LINQ II · LUTONIX · LUX-DX · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · MERLIN@HOME · MITRACLIP · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · MoMe Kardia · NEXLETOL · NEXLIZET · ONPATTRO · ONYX FRONTIER · OPSUMIT MACITENTAN · OPTIMIZER · Optis Coronary Imaging System · Ozempic · PRADAXA · PRALUENT · QUARTET · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESOLUTE ONYX · RESONATE · Repatha · Resolute · Reveal LINQ · Rotarex · SAPIEN 3 Ultra RESILIA · SYNERGY · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TactiCath Quartz CFA Catheter · ULTRASCORE · UPTRAVI · VENASEAL · VENOVO · VERQUVO · Varithena Administration Pack · Vein Treatment - Other Products · Veltassa · VersaCross Access Solution · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT · Xience Sierra Coronary Stent System · ZILVER PTX · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $430 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
170
Per 100K population
3.6
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE TOMBALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khan is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khan performed 1,169 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $23,712 from 56 companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other cardiovascular diseases in Tomball?
Dr. Khan's average Medicare payment per service is $152. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Tomball
Browse cardiovascular diseases in Tomball ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology